Biolevate Raises €30M Series A for Life Sciences AI

Paris-based Biolevate has raised €30 million in Series A funding co-led by RAISE France and Orange Ventures, with MSD Global Health Innovation Fund and EQT Ventures participating. The company's agentic AI platform automates scientific and regulatory workflows for life sciences, running up to 100,000 agents concurrently. Biolevate serves more than a dozen enterprise customers and is opening a Boston office to expand into the US.